cocaine hydrochloride · Lxo Ireland · NDA 209963
Goprelto
Earliest generic entry, as listed
7 Feb 2037
Blocked by patent: US 10016407, US 10149843, US 10149843, US 10231961, US 10413505, US 10420760, US 10857095, US 10894012, US 10933060, US 10973811, US 10987347, US 11040032, US 9867815, US 9867815, US 9867815.
Listed patents · 15 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10016407 | use U-2329 | 7 Feb 2037 |
| US 10149843 | use U-2478 | 7 Feb 2037 |
| US 10149843 | use U-2479 | 7 Feb 2037 |
| US 10231961 | product | 7 Feb 2037 |
| US 10413505 | use U-2479 | 7 Feb 2037 |
| US 10420760 | use U-2478 | 7 Feb 2037 |
| US 10857095 | use U-3014 | 7 Feb 2037 |
| US 10894012 | use U-3014 | 7 Feb 2037 |
| US 10933060 | use U-3014 | 7 Feb 2037 |
| US 10973811 | use U-2226 | 7 Feb 2037 |
| US 10987347 | use U-2225 | 7 Feb 2037 |
| US 11040032 | product | 7 Feb 2037 |
| US 9867815 | use U-2226 | 7 Feb 2037 |
| US 9867815 | use U-2225 | 7 Feb 2037 |
| US 9867815 | use U-2227 | 7 Feb 2037 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209963 · 001 · RLD | solution, nasal | 4% | 7 Feb 2037 |